抗精神病药未治精神分裂症或精神病患者认知功能与谷氨酸能代谢物及GABA水平的关联
该研究纳入56例抗精神病药未治的精神分裂症或精神病性障碍患者和51名健康对照,用磁共振波谱测量背侧前扣带回和左侧丘脑的谷氨酸、谷氨酰胺及GABA水平并评估认知。患者组背侧前扣带回GABA较低,精神分裂症亚组丘脑谷氨酸较高;背侧前扣带回Glx与工作记忆和注意力正相关且两组无差异。
要点
- 抗精神病药未治患者背侧前扣带回GABA水平低于健康对照(p = .03)。
- 精神分裂症亚组丘脑谷氨酸水平高于对照(p = .01)。
- 背侧前扣带回Glx与工作记忆(p = .005)和注意力(p = .035)正相关。
核心结论
- 谷氨酸能代谢物与认知功能呈正相关,且该关联在患者与健康对照间无差异。
- 背侧前扣带回GABA能水平降低涉及精神分裂症和精神病性障碍。
- 丘脑谷氨酸水平升高似乎参与精神分裂症病理生理。
研究设计与样本
- 研究纳入56例抗精神病药未治的精神分裂症或精神病性障碍患者和51名健康对照。
- 采用磁共振波谱测量背侧前扣带回的谷氨酸、谷氨酰胺(Glx)和GABA水平及左侧丘脑的谷氨酸和Glx水平。
- 评估注意力、工作记忆和智商等认知域。
主要发现
- 全部患者组背侧前扣带回GABA水平较低(p = .03)。
- 精神分裂症诊断亚组丘脑谷氨酸水平较高(p = .01)。
- 背侧前扣带回和丘脑Glx水平组间无差异。
- 背侧前扣带回Glx与工作记忆正相关(对数转换:b = -.016,p = .005;分数越高表示表现越差)。
- 背侧前扣带回Glx与注意力正相关(b = .056,p = .035),但注意力关联未通过多重比较校正。
关键数值与推荐
- 背侧前扣带回GABA组间差异p = .03。
- 精神分裂症亚组丘脑谷氨酸组间差异p = .01。
- 背侧前扣带回Glx与工作记忆关联b = -.016,p = .005。
- 背侧前扣带回Glx与注意力关联b = .056,p = .035。
临床怎么用
- 提示伴认知缺损的首发患者可能从谷氨酸调节化合物中获益。
- 背侧前扣带回GABA降低和丘脑谷氨酸升高或可作为精神分裂症及精神病性障碍的病理生理线索。
局限性
- 注意力与Glx的关联未通过多重比较校正。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Abnormal glutamate and GABA (gamma-aminobutyric acid) levels have been found in the early phase of schizophrenia and may underlie cognitive deficits. However, the association between cognitive function and levels of glutamatergic metabolites and GABA has not been investigated in a large group of antipsychotic-naïve patients. METHODS: In total, 56 antipsychotic-naïve patients with schizophrenia or psychotic disorder and 51 healthy control subjects underwent magnetic resonance spectroscopy to measure glutamate, glutamate+glutamine (Glx), and GABA levels in dorsal anterior cingulate cortex (ACC) and glutamate and Glx levels in left thalamus. The cognitive domains of attention, working memory, and IQ were assessed. RESULTS: The whole group of antipsychotic-naïve patients had lower levels of GABA in dorsal ACC (p = .03), and the subgroup of patients with a schizophrenia diagnosis had higher glutamate levels in thalamus (p = .01), but Glx levels in dorsal ACC and thalamus did not differ between groups. Glx levels in dorsal ACC were positively associated with working memory (logarithmically transformed: b = -.016 [higher score indicates worse performance], p = .005) and attention (b = .056, p = .035) in both patients and healthy control subjects, although the association with attention did not survive adjustment for multiple comparisons. CONCLUSIONS: The findings suggest a positive association between glutamatergic metabolites and cognitive function that do not differ between patients and healthy control subjects. Moreover, our data indicate that decreased GABAergic levels in dorsal ACC are involved in schizophrenia and psychotic disorder, whereas increased glutamate levels in thalamus seem to be implicated in schizophrenia pathophysiology. The findings imply that first-episode patients with cognitive deficits may gain from glutamate-modulating compounds.
引用
- Bojesen KB, Broberg BV, Fagerlund B, et al. Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis. Biol Psychiatry. 2020. PMID: 32928500. doi:10.1016/j.biopsych.2020.06.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。